How Telix Pharmaceuticals Limited stacks up

TLX · against 588 other Healthcare companies listed in US-listed

Valuation

31/ 100

Below the middle of the pack.

Ranked #301 of 589 · scores higher than 49% of peers

Bars: peers in each 10-point band of the valuation score

75 peers with a valuation score of 30–39, including TLX · Click a bar to see the companies

Why valuation scores 31?

Weighted metrics compared with all Healthcare companies.

Mainly because of its EBITDA yield, which is weaker than most Healthcare peers.

less operating profit (EBITDA) for the company's total value: weaker than 61% of peers. EBITDA yield: 0.8% vs peer median 4.0%
Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -0.1% vs peer median 1.5%
Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -0.7% vs peer median 0.0%

Metric by metric

Position: dot = TLX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	TLX	Peer median	Better than	Position among peers	Weight
Earnings yieldHigher is better · 577 reported	1.1%	-4.3%	69%		30%
EBITDA yieldHigher is better · 578 reported	2.1%	-0.8%	58%		50%
Free cash flow yieldHigher is better · 553 reported	Not reported	-2.3%	—	—	20%
Book yieldHigher is better · 587 reported	15.9%	25.9%	35%		Context only

A metric that is not reported is left out of the score; the other weights are rescaled.

Ranking by valuation score

Top 5 and the companies ranked around TLX

Rank	Company	Market cap	Valuation	Overall
1	Clinuvel Pharmaceuticals LimitedCUVL · US-listed	256M USD	98	80
2	Arbutus Biopharma CorporationABUS · US-listed	595M USD	96	97
2	CorMedix Inc.CRMD · US-listed	433M USD	96	81
2	Community Health Systems, Inc.CYH · US-listed	289M USD	96	57
2	InMode Ltd.INMD · US-listed	810M USD	96	69
⋯
298	Corcept Therapeutics IncorporatedCORT · US-listed	8.9B USD	32	51
298	Omada Health, Inc.OMDA · US-listed	1.1B USD	32	61
298	Talkspace IncTALK · US-listed	871M USD	32	53
301	NeoGenomics, Inc.NEO · US-listed	2.2B USD	31	36
301	Telix Pharmaceuticals LimitedTLX · US-listed	3.1B USD	31	46
303	Aurora Cannabis Inc.ACB · US-listed	327M USD	30	40
303	Canopy Growth CorporationCGC · US-listed	318M USD	30	26
303	iRhythm Holdings, Inc.IRTC · US-listed	4.2B USD	30	41
303	Oculis Holding AGOCS · US-listed	424M USD	30	45

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…